Howard Hughes Medical Institute Decreases Holdings in Humana Inc. (HUM)

Howard Hughes Medical Institute trimmed its holdings in Humana Inc. (NYSE:HUM) by 36.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 744 shares of the insurance provider’s stock after selling 434 shares during the quarter. Howard Hughes Medical Institute’s holdings in Humana were worth $179,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in HUM. BlackRock Inc. lifted its stake in Humana by 2,281.7% in the 1st quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock worth $2,553,487,000 after purchasing an additional 11,867,056 shares in the last quarter. FMR LLC lifted its stake in Humana by 57.9% in the 1st quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock worth $1,041,184,000 after purchasing an additional 1,851,197 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Humana by 84.3% in the 1st quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock worth $554,867,000 after purchasing an additional 1,231,400 shares in the last quarter. Wellington Management Group LLP lifted its stake in Humana by 2,651.1% in the 1st quarter. Wellington Management Group LLP now owns 775,755 shares of the insurance provider’s stock worth $159,915,000 after purchasing an additional 747,557 shares in the last quarter. Finally, AQR Capital Management LLC lifted its stake in Humana by 413.8% in the 1st quarter. AQR Capital Management LLC now owns 736,019 shares of the insurance provider’s stock worth $151,723,000 after purchasing an additional 592,772 shares in the last quarter. 95.12% of the stock is currently owned by institutional investors and hedge funds.

HUM has been the topic of a number of research reports. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research note on Thursday, June 1st. Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research note on Friday, June 9th. BidaskClub raised shares of Humana from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. Citigroup Inc. initiated coverage on shares of Humana in a research note on Wednesday, June 28th. They issued a “buy” rating and a $275.00 target price on the stock. Finally, Bank of America Corporation raised their target price on shares of Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, July 14th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. Humana has a consensus rating of “Buy” and a consensus price target of $244.35.

Humana Inc. (NYSE:HUM) traded down 0.046% during mid-day trading on Monday, reaching $249.165. 100,785 shares of the company traded hands. The stock has a 50-day moving average of $250.25 and a 200 day moving average of $231.50. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $259.76. The stock has a market capitalization of $36.01 billion, a PE ratio of 20.497 and a beta of 0.87.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.08 by $0.41. The company had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same quarter last year, the firm posted $2.30 earnings per share. Equities research analysts expect that Humana Inc. will post $11.55 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Tuesday, August 29th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.

ILLEGAL ACTIVITY WARNING: “Howard Hughes Medical Institute Decreases Holdings in Humana Inc. (HUM)” was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.chaffeybreeze.com/2017/09/18/howard-hughes-medical-institute-decreases-holdings-in-humana-inc-hum.html.

In other news, VP Timothy S. Huval sold 7,803 shares of the stock in a transaction on Friday, September 1st. The shares were sold at an average price of $258.14, for a total value of $2,014,266.42. Following the completion of the sale, the vice president now owns 8,831 shares of the company’s stock, valued at $2,279,634.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP M Todoroff Christopher sold 22,935 shares of the stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $252.52, for a total transaction of $5,791,546.20. Following the completion of the sale, the vice president now directly owns 24,001 shares of the company’s stock, valued at approximately $6,060,732.52. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 60,566 shares of company stock worth $15,326,746. 0.80% of the stock is currently owned by insiders.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply